Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: A retrospective study

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 5, 2006, Pages 693-695

  Virtanen, Hannele M ^a   Reitamo, Sakari ^a   Kari, Marjatta ^b   Kari, Osmo ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Atopic blepharo conjuctivitis; Conjuctival cytology; Eosinophilis; Lacrolimus ointment; Lymphocytes; Neutrophils

Indexed keywords

ANTIHISTAMINIC AGENT; CROMOGLYCATE DISODIUM; GLUCOCORTICOID; TACROLIMUS;

ADULT; ANTERIOR EYE CHAMBER; ARTICLE; ATOPIC BLEPHAROCONJUNCTIVITIS; ATOPIC KERATOCONJUNCTIVITIS; BLEPHARITIS; BURNING SENSATION; CLINICAL ARTICLE; CONJUNCTIVA DISEASE; CONJUNCTIVAL BIOPSY; CONJUNCTIVITIS; CONTROLLED STUDY; CORNEA DISEASE; CYTOPATHOLOGY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; DRUG SAFETY; EYE INFECTION; EYE REFRACTION; EYELID DISEASE; FEMALE; FOLLOW UP; HEAT SENSATION; HERPES SIMPLEX; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INFLAMMATORY CELL; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; KERATITIS; LENS DISEASE; LEUKOPENIA; LYMPHOCYTOPENIA; MALE; NEUTROPENIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; REFRACTION ERROR; RETINA DISEASE; RETROSPECTIVE STUDY; SCORING SYSTEM; SQUAMOUS CELL METAPLASIA; SYMPTOMATOLOGY; VISUAL ACUITY;

ADULT; BLEPHARITIS; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 33748258192     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00699.x     Document Type: Article

References (18)

1. Bielory L, Bonini S & Bonini S (2002): Allergic eye disorders. Clin Allergy Immunol 16: 311-323.
2. Bonini S, Barney NP, Sciavone M et.al. (1992): Effectiveness of nedocromil sodium 2% eyedrops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis. Eye 6: 648-652.
3. Bonini S, Schiavone M, Bonini S et.al. (1997): Efficacy of lodoxamide eyedrops on mast cells and eosinophils after allergen challenge in atopic conjunctivitis. Ophthalmology 104: 849-853.
4. Ciprandi G, Cosentino C, Milanese M & Tosca MA (2003): Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reaction. Ann Allergy Asthma Immunol 90: 434-438.
5. Foster SC, Rice BA & Dutt JE (1991): Immunopathology of atopic keratoconjunctivitis. Ophthalmology 98: 1190-1196.
6. Kang S, Lucky AW, Pariser D et.al. (2001): Longterm safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 44 (1): 58-64.
7. Kari O (1988): Atopic conjunctivitis. A cytologic examination. Acta Ophthalmol (Copenh) 66: 381-386.
8. Kyllönen H, Remitz A, Mandelin J et.al. (2004): Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis. Br J Dermatol 150: 1174-1181.
9. Mayer K, Reinhard T, Reis A et.al. (2001): 01% FK 506-Salbe - Eine neue therapeutische Option bei der atopischen Blepharitis. Klinische Studie an 14 Patienten. Klein Monatsbl Augenheilkd 218: 733-736.
10. Nghiem P, Pearson G & Langley RG (2002): Tacrolimus and pimecrolimus: From clever procaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 46: 228-241.
11. Nishino K, Fukushima A, Okamoto S et.al. (2002): Suppression of experimental immune-mediated blepharoconjunctivitis in Brown Norway rats by topical application of FK506. Graefes Arch Clin Exp Ophthalmol 240: 137-143.
12. Peuravuori H, Kari O, Peltonen S et.al. (2004): Group IIA phospholipase AZ content of tears in patients with atopic blepharoconjuctivitis. Graefes Arch Clin Exp Ophthalmol 242: 9986-9989.
13. Reitamo S, Remitz A, Kyllönen H et.al. (2002a): Topical non-glucocorticoid immunomodulation in the treatment of atopic dermatitis. Am J Clin Dermatol 3: 381-388.
14. Reitamo S, Rustin M, Ruzicka T et.al. (2002b): Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 109: 547-555.
15. Reitamo S, Van Leent EJ, Ho V et.al. (2002c): Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate in children with atopic dermatitis. J Allergy Clin Immunol 109: 539-546.
16. Reitamo S, Wollenberg A, Schöpf E et.al. (2000): Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 136: 999-1006.
17. Rikkers SM, Holland GN, Drayton GE et.al. (2003): Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol 135: 297-302.
18. Sengoku T, Sakuma S, Satoh S et.al. (2003): Effect of FK506 eyedrops on late and delayed-type responses in ocular allergy models. Clin Exp Allergy 33: 1555-1560.